These findings align with the results from the TIMER2 database and suggested that B3GNT5 may contribute to decreased infiltration of B lymphocytes and CD8+ T lymphocytes, while promoting the accumulation of MDSCs, Tregs, and tumor-associated macrophages (TAMs), thus potentially explaining its role as a risk factor in various tumor types. Here, B3GNT5 is linked to neoplasm.